Efectos adversos del tratamiento antirretroviral en niños infectados por el virus de la inmunodeficiencia humana

Usuga X

ARTÍCULO DE REVISIÓN

Efectos adversos del tratamiento antirretroviral en niños infectados por el virus de la LQPXQRGHÀFLHQFLDKXPDQD Adverse effects of antiretroviral treatment in children infected by the human LPPXQRGHÀFLHQF\YLUXV ;LRPDUD8VXJD

Resumen

'HVGHTXHVHFRQRFLyODLQIHFFLyQSRUHOYLUXVGHODLQPXQRGHÀFLHQFLDKXPDQD9,+ VHKDQGLDJQRVWLFDGRPiVGHPLOORQHVGHQLxRVLQIHFWDGRV DQLYHOPXQGLDO&RQHVWHFRQRFLPLHQWRYLQRWDPELpQODJHQHUDFLyQGHOWUDWDPLHQWR+$$57Highly Active Antiretroviral Therapy TXHORJUyPHMRUDU ODFDOLGDGGHYLGD\ODH[SHFWDWLYDGHYLGDGHORVODFWDQWHVLQIHFWDGRV6LQHPEDUJRORVLQGLYLGXRVTXHUHFLEHQWUDWDPLHQWRSUHVHQWDQFRQGLFLRQHV SDUWLFXODUHVTXHORVKDFHQFRQVWLWXLUXQJUXSRGHLQGLYLGXRVFRQQHFHVLGDGHVGHDWHQFLyQ\FXLGDGRGLIHUHQWHV(QHVWDUHYLVLyQVHDERUGDQORV DVSHFWRVFOtQLFRVPiVUHOHYDQWHVTXHDTXHMDQDORVQLxRVLQIHFWDGRVSRU9,+TXHUHFLEHQWUDWDPLHQWRDQWLUUHWURYLUDODOWDPHQWHDFWLYR Palabras clavesLQIDQWHV9,++$$57

Abstract

6LQFHWKHKXPDQLPPXQRGHÀFLHQF\YLUXV+,9 ZDVNQRZQPRUHWKDQPLOOLRQLQIHFWHGFKLOGUHQDURXQGWKHZRUOGKDYHEHHQGLDJQRVHG:LWK WKLVNQRZOHGJHDOVRFDPHWKHDGYHQWRIWKH+LJKO\$FWLYH$QWLUHWURYLUDO7KHUDS\+$$57 ZKLFKKDVDFKLHYHGDEHWWHUTXDOLW\RIOLIHDQGJUHDWHU OLIHH[SHFWDQF\RIXQZHDQHGLQIHFWHGEDELHV+RZHYHUSHRSOHUHFHLYLQJWKLVWKHUDS\SUHVHQWSDUWLFXODUFRQGLWLRQVWKDWPDNHWKHPDSRSXODWLRQ ZLWKGLIIHUHQWDWWHQWLRQDQGFDUHQHHGV7KLVUHYLHZDGGUHVVHVWKHPRVWUHOHYDQWFOLQLFDODVSHFWVSUHVHQWLQ+,9LQIHFWHGFKLOGUHQUHFHLYLQJ+$$57 Key wordsFKLOG+,9+$$57

Introducción (O 9,+ \ HO 9,+ FRPR DJHQWHV FDXVDOHV GH ODLQPXQRGHÀFLHQFLDKXPDQDKDQVLGRUHVSRQVDEOHVGHODLQIHFFLyQGHPiVGHPLOORQHVGH QLxRVGHVGHVXDSDULFLyQ \GHODLQIHFFLyQGH DSUR[LPDGDPHQWHPHQRUHVGHDxRV HQHO(1) (QORV~OWLPRVDxRVODLQFLGHQFLDGHHVWDLQIHFFLyQHQODFWDQWHVKDWHQLGRXQJUDQGHVFHQVRHQ ORVSDtVHVGHVDUUROODGRVJUDFLDVDODLPSOHPHQWDFLyQGHHVWUDWHJLDVTXHSHUPLWHQHOGLDJQyVWLFR WHPSUDQR GH OD LQIHFFLyQ HQ PXMHUHV HPEDUD]DGDV \ SRU FRQVLJXLHQWH HO WUDWDPLHQWR DQWLUUHWURYLUDOSDUDODSUHYHQFLyQGHODWUDQVPLVLyQYHUWLFDO  (QFDPELRDSHVDUGHOHVWDEOHFLPLHQWRGHHVWUDWHJLDVVLPLODUHVHQODPD\RUtD  *UXSR,QIHWWDUH)DFXOWDGGH0HGLFLQD8QLYHUVLGDG&RRSHUDWLYD GH&RORPELD0HGHOOtQ&RORPELD



$62&,$&,Ï1&2/20%,$1$'(,1)(&72/2*Ë$

GHSDtVHVHQGHVDUUROORRWUDVFRQGLFLRQHVFRPR ODIDOWDGHUHFXUVRVODSRFDGLVSRQLELOLGDGGHORV PHGLFDPHQWRV\GHODVSUXHEDVGLDJQyVWLFDVHQ ORV VHUYLFLRV GH VDOXG SULQFLSDOPHQWH HQ iUHDV UXUDOHVKDQLPSHGLGRTXHODWDVDGHWUDQVPLVLyQ YHUWLFDOKD\DWHQLGRHOPLVPRLPSDFWR (VWRVH YHUHÁHMDGRHQUHJLRQHVFRPR$VLDFHQWUDOFRQ QLxRVLQIHFWDGRVHQHOHVWHDVLiWLFR FRQ  QLxRV \ &HQWURDPpULFD \ 6XUDPpULFD FRQFHUFDGHQLxRVLQIHFWDGRVHQHVHPLVPRDxRVLQFRQWDUHQ&RORPELDFRQHVWHGDWR(1) $ ÀQDOHV GH  VH HVWLPDED TXH HQ &RORPELD KDEtD HQWUH  \  QLxRV LQIHFWDGRV (3) \XQUHSRUWHQRRÀFLDOHQHODxRLQGLFDEDTXHVHKDEtDQUHJLVWUDGRQLxRV\DGROHVFHQWHVFRQODLQIHFFLyQLQFOXVRDOOtVHVHxDOD TXHKD\XQJUDQVXEUHJLVWUR\TXHSRVLEOHPHQ5HFLELGR$FHSWDGR &RUUHVSRQGHQFLD;LRPDUD8VXJD3HULOOD&DOOH)DFXOWDGGH 0HGLFLQD0HGHOOtQ&RORPELD7HOpIRQR H[WHQVLyQ &RUUHRHOHFWUyQLFR[LRPDUDXVXJD#FDPSXVXFFHGXFR

,QIHFWLR 

(IHFWRVDGYHUVRVGHOWUDWDPLHQWRDQWLUUHWURYLUDOHQQLxRVLQIHFWDGRVSRUHOYLUXVGHODLQPXQRGHÀFLHQFLDKXPDQD

WHHOQ~PHURUHDOVHDPD\RU(4)(VSUHFLVDPHQWH HVWDSREODFLyQGHODFWDQWHVLQIHFWDGRVODTXHVH FRQVWLWX\H HQ XQ JUXSR SDUWLFXODU GH DWHQFLyQ KDFLpQGRVH QHFHVDULR H LQGLVSHQVDEOH WHQHU XQ FRQRFLPLHQWR DPSOLR VREUH ORV DVSHFWRV LQPXQROyJLFRV FOtQLFRV PHWDEyOLFRV \ QHXUROyJLFRV UHODFLRQDGRV FRQ HO WUDWDPLHQWR DQWLUUHWURYLUDO GHELGRDTXHHVWDSREODFLyQD~QVLJXHHQFUHFLPLHQWRHQQXHVWURGHSDUWDPHQWR\HQHOSDtV /RVGLYHUVRVPHGLFDPHQWRVFRQWUDHO9,+VHKDQ FODVLÀFDGR VHJ~Q OD PROpFXOD VREUH OD TXH DFW~DQ HQLQKLELGRUHVGHSURWHDVDVLQKLELGRUHVGH ODWUDQVFULSWDVDLQYHUVDLQKLELGRUHVGHODLQWHJUDVDHLQKLELGRUHVGHODIXVLyQRGHODHQWUDGDWDEOD (OWUDWDPLHQWRDQWLUUHWURYLUDOGHJUDQDFWLYLGDG Highly Active Antiretroviral Therapy +$$57 FRQVLVWHHQHOXVRGHWUHVIiUPDFRVFRPR PtQLPRTXHSHUWHQHFHQDORVGLIHUHQWHVJUXSRV PHQFLRQDGRV DQWHULRUPHQWH \ TXH FRQVWD JHQHUDOPHQWH GH GRV LQKLELGRUHV GH OD WUDQVFULSWDVDXQRQXFOHyVLGR\RWURQRQXFOHyVLGR$OVHU XQWUDWDPLHQWRFRQWUDYDULRVEODQFRVHOLPSDFWR VREUH OD UHSOLFDFLyQ YLUDO HV EDVWDQWH HIHFWLYR \ ORJUDGLVPLQXLUODFDQWLGDGGHiFLGRULERQXFOHLFR $51  YLUDO SODVPiWLFR KDVWD QLYHOHV LQGHWHFWDEOHV 3RU FRQVLJXLHQWH OD EDMD FDQWLGDG GH SURJHQLHYLUDOUHSHUFXWHHQXQPtQLPRGDxRFHOXODU \SHUPLWHTXHORVLQGLYLGXRVLQIHFWDGRVSXHGDQ UHVWDEOHFHU VXV QLYHOHV GH OLQIRFLWRV 7 &' \ RWUDVSREODFLRQHVFHOXODUHVWDPELpQDIHFWDGDV /D2UJDQL]DFLyQ0XQGLDOGHOD6DOXG206 UHFRPLHQGDTXHWRGRVORVQLxRVPHQRUHVGHGRV DxRV UHFLEDQ WUDWDPLHQWR DQWLUUHWURYLUDO (1) (O SURWRFRORUHFRPHQGDGRSDUDORVSDtVHVHQGHVDUUROORFRQVLVWHHQGRVLVÀMDVGHHVWDGXYLQDODPLGXYLQD\QHYLUDSLQD 3DUDODLPSOHPHQWDFLyQ GHHVWHHVTXHPDVHGHEHWHQHUHQFXHQWDTXH VLODPDGUHUHFLELyQHYLUDSLQDGXUDQWHHOHPEDUD]RKD\PD\RUHVSUREDELOLGDGHVGHTXHHOYLUXV WUDQVPLWLGRDOQLxR\DKD\DFUHDGRUHVLVWHQFLDD HVWH PHGLFDPHQWR \ SRU OR WDQWR QR VH UHFRPLHQGDHVWHIiUPDFRDHVRVODFWDQWHV$GHPiV VH KD UHWLUDGR HO XVR GH OD HVWDGXYLQD SRU VXV HIHFWRVWy[LFRV

,QIHFWLR 

(O HVWDEOHFLPLHQWR GHO WUDWDPLHQWR DQWLUUHWURYLUDO KD SHUPLWLGR TXH ORV LQGLYLGXRV LQIHFWDGRV PHMRUHQ QRWDEOHPHQWH VX FDOLGDG GH YLGD 3RU HMHPSORODVPDQLIHVWDFLRQHVFOtQLFDVWtSLFDVREVHUYDGDVHQORVLQGLYLGXRVLQIHFWDGRVHVSHFLDOPHQWH ODV HQIHUPHGDGHV DVRFLDGDV D XQ EDMR UHFXHQWRGHOLQIRFLWRV7&'VHSUHVHQWDQFRQ PHQRUIUHFXHQFLDHQORVLQGLYLGXRVTXHUHFLEHQ tratamiento   1R REVWDQWH ODV SHUVRQDV LQIHFWDGDV TXH HVWiQ EDMR WUDWDPLHQWR SUHVHQWDQ QXHYRVVtQGURPHVDVRFLDGRVFRQVXXVR (VWDUHYLVLyQVHHQIRFDHQUHYLVDUYDULRVDVSHFWRVUHODFLRQDGRVFRQODWHUDSLD+$$57HQQLxRV LQIHFWDGRV3DUDVXHODERUDFLyQVHKL]RXQDE~VTXHGDHQODVEDVHVGHGDWRV3XEPHG0HGOLQH 2YLG XWLOL]DQGR ORV VLJXLHQWHV WpUPLQRV HIV infection children HAART metabolic disorders endocrinologic disorders lypodistrophy immunization \ adverse effects. 6HFRPELQDURQORVWpUPLQRV \ VH UHVWULQJLy OD ELEOLRJUDItD D DUWtFXORV RULJLQDOHV\DDOJXQDVUHYLVLRQHV Alteraciones metabólicas y endocrinas (QYDULRVHVWXGLRVVHKDGHPRVWUDGRTXHHOWUDWDPLHQWR DQWLUUHWURYLUDO VH DVRFLD FRQ OD DSDULFLyQ GH HIHFWRV VHFXQGDULRV PHWDEyOLFRV WDOHV FRPRGLVOLSLGHPLDV(11-13)UHVLVWHQFLDDODLQVXOLQD (14) \GLDEHWHVPHOOLWXV(15)ORVFXDOHVVRQIDFWRUHV GHULHVJRSDUDODHQIHUPHGDGFDUGLRYDVFXODU(16) /DVGLVOLSLGHPLDVHVWiQHVWUHFKDPHQWHOLJDGDVDO VtQGURPHGHUHGLVWULEXFLyQGHJUDVDVFRQRFLGR FRPROLSRGLVWURÀDHOFXDOVHDVRFLDDODUD]DDO HVWDGR FOtQLFR JUDYH SUHYLR DO WUDWDPLHQWR D OD GXUDFLyQGHODLQIHFFLyQSRU9,+\DOWUDWDPLHQWR FRQLQKLELGRUHVGHQXFOHyVLGRVGHODWUDQVFULStasa inversa (17)RFRQLQKLELGRUHVGHSURWHDVDV FRPRHOULWRQDYLU\HOQHOÀQDYLU(18)/DOLSRGLVWURÀDVHFDUDFWHUL]DSRUOLSRDWURÀDSHULIpULFDUHGLVWULEXFLyQGHODJUDVDYLVFHUDO\DQRUPDOLGDGHVHQ HOPHWDEROLVPRGHODVJUDVDV\GHODJOXFRVDHQ ORV LQGLYLGXRV LQIHFWDGRV EDMR WUDWDPLHQWR /RV PHFDQLVPRV ÀVLRSDWROyJLFRV TXH H[SOLFDQ ORV



Usuga X Tabla 1. 0HGLFDPHQWRVDQWLUUHWURYLUDOHV Clase

,QKLELGRUHVGHOD transcriptasa inversa QXFOHyWLGRV QXFOHyVLGRV(5)

Nombre genérico

Nombre comercial

=LGRYXGLQD

Retrovir

/DPLYXGLQD

(SLYLU

(PWULFLWDELQH

(PWULYD

$EDFDYLU

=LDJHQ

7HQRIRYLUGLVRSUR[LO IXPDUDWR

9LUHDG

7HQRIRYLU')\ HPWULFLWDELQH

7UXYDGD

'LGDQRVLQD

'LGDQRVLQD

6WDYXGLQD

6WDYXGLQD

=LGRYXGLQD\ ODPLYXGLQD

&RPELYLU

$EDFDYLU\ ODPLYXGLQD

(S]LFRP

$EDFDYLUODPLYXGLQD \]LGRYXGLQD

,QKLELGRUHVGHOD transcriptasa inversa no QXFOHyVLGRV(6)

,QKLELGRUHVGH proteasas (7)

,QKLELGRUHVGHOD HQWUDGD\GHODIXVLyQ(8) ,QKLELGRUHVGHOD LQWHJUDVD

7UL]LYLU

(IDYLUHQ]

6XVWLYD

(WUDYLULQH

,QWHOHQFH

'HODYLUGLQH

Rescriptor

1HYLUDSLQH

9LUDPXQH

(IDYLUHQ]WHQRIRYLU\ HPWULFLWDELQH

$WULSOD

Ritonavir

1RUYLU

6DTXLQDYLU

,QYLUDVH fortovase

,QGLQDYLU

&UL[LYDQ

1HOÀQDYLU

Viracept

$PSUHQDYLU

$JHQHUDVH

/RSLQDYLU\ULWRQDYLU

.DOHWUD

(QIXYLUWLGH

)X]HRQ

Maraviroc

6HO]HQWU\ FHOVHQWUL

5DOWHJUDYLU

,VHQWUHVV

EDMDGHQVLGDG/'/ DVRFLDGRVDOXVRGHLQKLELGRUHVGHSURWHDVDV  /RVQLxRVPHQRUHVGH GLH]DxRVSUHVHQWDQODVFRQFHQWUDFLRQHVPiVDOWDVGHFROHVWHUROWRWDO\OLSRSURWHtQDV/'/FRPSDUDGDVFRQODVGHQLxRVPD\RUHV (11)7DPELpQ VHKDQREVHUYDGREDMRVQLYHOHVGHDGLSRQHFWLQD \DXPHQWRGHODOLEHUDFLyQGHiFLGRVJUDVRVOLEUHVSRUHOWHMLGRDGLSRVRUHVLVWHQWHDODLQVXOLQD HQORVQLxRV ORFXDOHVWDUtDUHODFLRQDGRFRQOD SUHVHQFLDGHJUDVDDEGRPLQDOODOLSRKLSHUWURÀD \ODUHVLVWHQFLDDODLQVXOLQD  /D UHVLVWHQFLD D OD LQVXOLQD IXH XQD GH ODV SULPHUDVFRPSOLFDFLRQHVPHWDEyOLFDVUHSRUWDGDVFRQHO XVRGHODWHUDSLD+$$57/RVQLxRVSRVLWLYRVSDUD 9,+WUDWDGRVFRQLQKLELGRUHVGHQXFOHyVLGRVGHOD WUDQVFULSWDVD LQYHUVD VRQ TXLHQHV SUHVHQWDQ XQD PD\RUSUHYDOHQFLDGHUHVLVWHQFLDDODLQVXOLQDDOVHU FRPSDUDGRV FRQ DGROHVFHQWHV LQIHFWDGRV EDMR HO mismo tratamiento (11)HVWRVXPDGRDODSUHVHQFLD GHRWURVIDFWRUHVGHULHVJRWDOHVFRPRIDPLOLDUHV FRQ GLDEHWHV XQ tQGLFH GH PDVD FRUSRUDO LQFUHPHQWDGR\ODHGDGSXHGHFRQOOHYDUDODDSDULFLyQ GHGLDEHWHVPHOOLWXV 6HKDQSRVWXODGRYDULRV PHFDQLVPRVGHDFFLyQGHORVDQWLUUHWURYLUDOHVSDUD LQFUHPHQWDUODUHVLVWHQFLDDODLQVXOLQDGLUHFWDPHQWHDOFDXVDUGLVIXQFLyQPLWRFRQGULDOHQHOP~VFXOR \FRQHOORDOWHUDUODUHVSXHVWDDODLQVXOLQD RLQGLUHFWDPHQWHFRPRXQDFRQVHFXHQFLDGHGHIHFWRV HQHOPHWDEROLVPRGHORVOtSLGRVGHULYDGRVGHOD WR[LFLGDGDQWLUUHWURYLUDOFRPRODUHVLVWHQFLDDODLQVXOLQDREVHUYDGDHQORVSDFLHQWHVFRQOLSRGLVWURÀD DVRFLDGDDO9,+(14) Alergias

FDPELRV PHWDEyOLFRV VRQ FRPSOHMRV \ GLItFLOHV GHHOXFLGDUGHELGRDODGLÀFXOWDGGHVHSDUDUORV HIHFWRVGHODLQIHFFLyQper seGHORVHIHFWRVGH ODWHUDSLD+$$57DGHPiVGHODVHQIHUPHGDGHV FRQFRPLWDQWHV\ODYXOQHUDELOLGDGLQGLYLGXDO (Q OD PD\RUtD GH QLxRV LQIHFWDGRV SRU 9,+ VH KDQHQFRQWUDGREDMDVFRQFHQWUDFLRQHVGHOLSRSURWHtQDVGHDOWDGHQVLGDG+'/ \HQODPLQRUtD GHHOORVVHKDQREVHUYDGRDOWRVQLYHOHVGHFROHVWHUROWRWDOGHWULJOLFpULGRV\GHOLSRSURWHtQDVGH



$62&,$&,Ï1&2/20%,$1$'(,1)(&72/2*Ë$

+D\ XQD PD\RU LQFLGHQFLD GH HQIHUPHGDGHV DOpUJLFDV HQ QLxRV SRVLWLYRV SDUD 9,+ WUDWDGRV FRQODWHUDSLD+$$57TXHHQDTXHOORVVLQWUDWDPLHQWR(QHVWXGLRVUHFLHQWHVVHGHPXHVWUDTXH ORV QLxRV HQ WUDWDPLHQWR DQWLUUHWURYLUDO SUHVHQWDQPiVDVPD\GHUPDWLWLVDWySLFDLJXDODQGROD LQFLGHQFLD\SUHYDOHQFLDGHHVWDVHQIHUPHGDGHV HQ QLxRV VLQ 9,+ OR TXH VH GHEH D OD UHFRQVWLWXFLyQLQPXQROyJLFDORJUDGDGHVSXpVGHOWUDWDPLHQWRDQWLUUHWURYLUDO 

,QIHFWLR 

(IHFWRVDGYHUVRVGHOWUDWDPLHQWRDQWLUUHWURYLUDOHQQLxRVLQIHFWDGRVSRUHOYLUXVGHODLQPXQRGHÀFLHQFLDKXPDQD

Complicaciones neurológicas y psiquiátricas /DFRPSOHMLGDGGHORVVLVWHPDVQHXUROyJLFR\SVLFROyJLFRKDKHFKRGLItFLOGHWHUPLQDUORVHIHFWRVGH ODLQIHFFLyQHLQFOXVRGHOWUDWDPLHQWRDQWLUUHWURYLUDOHQHOORV$SHVDUGHHOORHQYDULRVHVWXGLRVGH DGXOWRVLQIHFWDGRVVHGHPXHVWUDTXHHQHOFXUVR GH OD LQIHFFLyQ VH REVHUYDQ FDPELRV FRJQLWLYRV PRGHUDGRV FRPR GpÀFLW HQ OD DWHQFLyQ HQ OD PHPRULDHQHOSURFHVDPLHQWRGHODLQIRUPDFLyQ \ HQ OD IXQFLyQ PRWRUD ÀQD   SHUR DXQTXH DOJXQDVGHHVWDVPDQLIHVWDFLRQHVGHVDSDUHFHQFRQ HOWUDWDPLHQWRWDPELpQVHSXHGHQSUHVHQWDURWUDV FRPSOLFDFLRQHVDFDXVDGHODWHUDSLD+$$57WDOHV FRPRDOWHUDFLRQHVSVLTXLiWULFDV\GHOKXPRUDOWHUDFLRQHVQHXURPXVFXODUHV\GHWHULRURQHXUROyJLFR  &RPRSUXHEDGHHOORHOJUXSRGH1HXHQEXUJ DQDOL]yFHUHEURVSRVWPyUWHP\FRQFOX\yTXH GHVGHHOXVRGHODWHUDSLD+$$57ODLQFLGHQFLDGH OD HQFHIDORSDWtDSRU9,+VHLQFUHPHQWyVLJQLÀFDtivamente   OR TXH SXHGH VXJHULU TXH HO WUDWDPLHQWRSRGUtDHVWDUJHQHUDQGRXQGDxRFHUHEUDO RTXHQRHYLWDHOGDxRFDXVDGRSRUHOYLUXVper se. /RV QLxRV LQIHFWDGRV SRU 9,+ SUHVHQWDQ JUDYHV DOWHUDFLRQHV GHO VLVWHPD QHUYLRVR FHQWUDO \ D PHQXGRVRQSURJUHVLYDV\VHUHÁHMDQHQGpÀFLW FRJQLWLYRGHOOHQJXDMHPRWRU\GHOFRPSRUWDPLHQWR(QWUHHOODVVHHQFXHQWUDQODHQFHIDORSDWtDREVHUYDGDHQPHQRUHVGHXQDxR HOWUDVWRUQRKLSHUFLQpWLFRHOWUDVWRUQRGHWLFVWUDQVLWRULRV\HOUHWUDVRPHQWDOOLJHURHQQLxRVPD\RUHV   ODV DOWHUDFLRQHV HPRFLRQDOHV UHODFLRQDGDV FRQHOFRQRFLPLHQWRGHOGLDJQyVWLFR\ODGHSUHVLyQ\WULVWH]DHQDGROHVFHQWHV  9DULRV JUXSRV HVWDGRXQLGHQVHV TXLVLHURQ HYDOXDU HO LPSDFWR GH ORV LQKLELGRUHV GH SURWHDVDV HQ ODV GHÀFLHQFLDV QHXURSVLFROyJLFDV TXH SUHVHQWDEDQ ORV ODFWDQWHV LQIHFWDGRV DQWHV GHO WUDWDPLHQWR PHGLDQWH XQ VHJXLPLHQWR SRU  VHPDQDV GHVSXpV GH HVWDEOHFLGR HO WUDWDPLHQWR /RV LQYHVWLJDGRUHV HQFRQWUDURQ TXH HQ ORV QLxRV TXH SUHVHQWDEDQ XQ GLDJQyVWLFR QHXUROyJLFR DQRUPDO DQWHV GHO WUDWDPLHQWR HUD PiV SUREDEOH TXH GHVDUUROODUDQ QXHYRV VtQWRPDV QHXUROyJLFRVHQODVVLJXLHQWHVVHPDQDVGHWUD-

,QIHFWLR 

tamiento   $GHPiV OOHJDURQ D OD FRQFOXVLyQ GHTXHDXQTXHHOWUDWDPLHQWRWHQtDXQLPSDFWR QRWRULRHQODFDUJDYLUDOVXHIHFWRHQHOIXQFLRQDPLHQWRQHXURSVLFROyJLFRIXHPtQLPR $OJXQDV GH ODV PDQLIHVWDFLRQHV PiV FRPXQHV GHGHWHULRURQHXUROyJLFRDVRFLDGRDOWUDWDPLHQWR DQWLUUHWURYLUDO HQ DGXOWRV VRQ HO GHOLULR   OD PDQtD   \ OD SROLQHXURSDWtD VLPpWULFD GLVWDO  (OXVRGHDQiORJRVGHQXFOHyVLGRVFRPROD HVWDYXGLQD OD GLGDQRVLQD \ HO ]DOFLWDELQH SXHGH VHU SUHGLFWRU GH OD SUHVHQFLD GH QHXURSDWtD SHULIpULFD VHQVRULDO   $OJXQRV HIHFWRV HQ HO VLVWHPDQHUYLRVRFHQWUDOGHOD]LGRYXGLQDVRQLQVRPQLRPLDOJLDHLQWHQVRVGRORUHVGHFDEH]D(33) /RVLQKLELGRUHVQRQXFOHyVLGRVGHODWUDQVFULSWDVD LQYHUVDKDQGHPRVWUDGRPHMRUDUODIXQFLyQGHOVLVWHPDQHUYLRVRFHQWUDOHQLQGLYLGXRVTXHSUHVHQWDQ DQRUPDOLGDGHV HQ OD IXQFLyQ PRWRUD (34) $ SHVDU GHHOORHOHIDYLUHQ]HVHO~QLFRPHGLFDPHQWRTXH SUHVHQWDHIHFWRVDGYHUVRVHQHOVLVWHPDQHUYLRVR FHQWUDOFRPRODGHSUHVLyQSURIXQGD\ODLGHDFLyQ VXLFLGD  WDPELpQVHKDDVRFLDGRFRQLQVRPQLR DOWHUDFLRQHV GHO VXHxR (37) LUULWDELOLGDG \ QHUviosismo (38) $GHPiV VH KD REVHUYDGR TXH ORV LQGLYLGXRVFRQDOWHUDFLRQHVQHXURSVLTXLiWULFDVGH EDVHSXHGHQWHQHUXQPD\RUULHVJRGHVXIULUDOWHUDFLRQHVGHELGDVDOXVRGHOHIDYLUHQ]  7HQLHQGRHQFXHQWDTXHORVLQKLELGRUHVGHSURWHDVDVWLHQHQPX\SRFDFDSDFLGDGGHWUDVSDVDU ODEDUUHUDKHPDWRHQFHIiOLFD\SHQHWUDUHQHOFHUHEUR VRQ PHGLFDPHQWRV TXH QR VH DVRFLDQ D HIHFWRVQHXUROyJLFRV6LQHPEDUJRHQVXVHVWXGLRV%RQIDQWL \*DWWL(41)UHSRUWDURQTXHORVDOWRVQLYHOHVHQSODVPDGHULWRQDYLURGHODFRPELQDFLyQULWRQDYLUVDTXLQDYLUVHFRUUHODFLRQDQFRQ DXPHQWRGHODLQFLGHQFLDGHHIHFWRVFRODWHUDOHV QHXUROyJLFRVORTXHVXJLHUHTXHHVWRVPHGLFDPHQWRV Vt SXHGHQ HVWDU HMHUFLHQGR DOJ~Q HIHFWR VREUH HO VLVWHPD QHUYLRVR 'DGR TXH HVWRV PHGLFDPHQWRVVHXVDQHQFRPELQDFLyQFRQORV LQKLELGRUHV GH OD WUDQVFULSWDVD LQYHUVD \ D TXH QRVRQXQDSULPHUDOtQHDGHWUDWDPLHQWRVHKD KHFKRGLItFLOGHWHUPLQDUORVHIHFWRVUHDOHVGHORV LQKLELGRUHVGHSURWHDVDV



Usuga X

/RVGDWRVDQWHULRUHVGHPXHVWUDQTXHORVPHGLFDPHQWRVXVDGRVHQODWHUDSLD+$$57SUHVHQWDQ XQSRWHQFLDOGDxRDQLYHOQHXURSVLFROyJLFRLQIRUWXQDGDPHQWH QR KD\ HVWXGLRV TXH DQDOLFHQ ORVHIHFWRVDGYHUVRVGHODWHUDSLD+$$57HQHO VLVWHPDQHUYLRVRGHORVQLxRVLQIHFWDGRVTXHUHFLEHQHVWHWUDWDPLHQWR Acidosis láctica e hiperlactatemia /DDFLGRVLVOiFWLFDHVGHÀQLGDFRPRQLYHOHVGHODFWDWRVpULFRDOWRVS+PHQRUGHELFDUERQDWR VpULFR\&2 HQFDQWLGDGHVEDMDV PLHQWUDVTXHOD KLSHUODFWDWHPLD VLQWRPiWLFD FRUUHVSRQGH D ODFWDWRVpULFRDOWR\QLYHOHVGH&2 S+\ELFDUERQDWR VpULFRV QRUPDOHV DGHPiV GH OD SUHVHQFLD GH ORV FRUUHVSRQGLHQWHVVLJQRV\VtQWRPDVTXHLQFOX\HQ DQRUH[LD SpUGLGD GH SHVR QHXURSDWtD SHULIpULFD GLVQHD FDQVDQFLR \ VtQWRPDV JDVWURLQWHVWLQDOHV LQHVSHFtÀFRVFRPRQD~VHDVYyPLWRGRORU\GLVWHQVLyQ DEGRPLQDO (VWDV GRV DOWHUDFLRQHV KDQ VLGR DPSOLDPHQWH GHVFULWDV HQ DGXOWRV TXH UHFLEHQWUDWDPLHQWRDQWLUUHWURYLUDOFRQWDVDVGHLQFLGHQFLDTXHYDUtDQHQWUH \(43)\WDVDV GHPRUWDOLGDGKDVWDGHSRUDFLGRVLVOiFWLFD (43) PLHQWUDVTXHHQHO~QLFRHVWXGLRHQQLxRVGH XQWRWDOGHVHKDOODURQFRQKLSHUODFWDWHPLD DVLQWRPiWLFDORVFXDOHVUHFLEtDQLQKLELGRUHVGHQXFOHyVLGRVGHODWUDQVFULSWDVDLQYHUVDDGHPiVHQFRQWUDURQODHGDGFRPRXQIDFWRUGHULHVJRSDUD OD SUHVHQWDFLyQ GH KLSHUODFWDWHPLD (44) $OLPHQWL \ VXJUXSR(45)HVWXGLDURQHOSRWHQFLDOWy[LFRGHOWUDWDPLHQWRHQUHFLpQQDFLGRVQRLQIHFWDGRVH[SXHVWRVDOWUDWDPLHQWRDQWLUUHWURYLUDOSHULQDWDOPHQWH\ HQFRQWUDURQDFLGHPLDOiFWLFDWUDQVLWRULDHQODPD\RUtDGHHOORVFXDQGRVHVXPLQLVWUDED]LGRYXGLQD Infecciones 6LELHQODSUHVHQFLDGHHQIHUPHGDGHVLQIHFFLRVDV KD GLVPLQXLGR HQ ORV QLxRV LQIHFWDGRV SRU 9,+ JUDFLDV DO HVWDEOHFLPLHQWR GHO WUDWDPLHQWR DQWLUUHWURYLUDO HQ DOJXQRV HVWXGLRV VH KD GHPRVWUDGR TXH DXQ EDMR HVWDV FLUFXQVWDQFLDV HOORV VLJXHQVLHQGRXQDSREODFLyQYXOQHUDEOH $XQTXHHVWD VLWXDFLyQ QRUHSUHVHQWDXQHIHFWR DGYHUVRGHOWUDWDPLHQWRDQWLUUHWURYLUDOHVXQDV-



$62&,$&,Ï1&2/20%,$1$'(,1)(&72/2*Ë$

SHFWR LPSRUWDQWH TXH YDOH OD SHQD DQDOL]DU HQ ORVSDFLHQWHVLQIHFWDGRV0HGLDQWHHODQiOLVLVGH XQD JUDQ FRKRUWH GH QLxRV SRVLWLYRV SDUD 9,+ SURYHQLHQWHVGHYDULRVSDtVHVGH$PpULFD/DWLQD VH HQFRQWUy TXH SUHVHQWDEDQ YDULRV SURFHVRV LQIHFFLRVRVFRPRQHXPRQtDEDFWHULDQDYDULFHODLQIHFFLRQHVSRUGHUPDWRÀWRVKHUSHVVLPSOH[ \ KHUSHV ]yVWHU RUDO HQ HVH PLVPR HVWXGLR VH compary HVWD FRKRUWH FRQ XQD GH ORV (VWDGRV 8QLGRV\VHREVHUYyTXHORVQLxRVSUHVHQWDEDQ ODVPLVPDVLQIHFFLRQHVSHURTXHODVLQFLGHQFLDV HUDQPD\RUHVHQHOSULPHUJUXSR  5HVXOWDGRV VLPLODUHV VH REWXYLHURQ HQ XQ HVWXGLR HQ %UDVLO GRQGH ODV LQIHFFLRQHV SRU EDFWHULDV OD QHXPRQta por Pneumocystis jirovecii OD VHSVLV\ODPHQLQJLWLVEDFWHULDQDIXHURQODVHQIHUPHGDGHV SRU PLFURRUJDQLVPRV RSRUWXQLVWDV PiVFRPXQHVHQWUHQLxRVHQWUDWDPLHQWR DQWLUUHWURYLUDO (48) (VWRV UHVXOWDGRV GHPXHVWUDQ TXH D SHVDU GHO WUDWDPLHQWR HQ HVWRV QLxRV SXHGHQSUHVHQWDUVHYDULDVHQIHUPHGDGHVLQIHFFLRVDVTXHGHSHQGHUiQGHODUHJLyQJHRJUiÀFD HQODTXHHVWpQXELFDGRVFX\DVFRQGLFLRQHVGH YLGDSUHFDULDVUHSHUFXWLUiQLQHYLWDEOHPHQWHHQOD SREODFLyQLQIDQWLOLQIHFWDGDSRU9,+

Discusión /D WHUDSLD +$$57 KD SHUPLWLGR XQ DSURSLDGR PDQHMR GH OD LQIHFFLyQ SRU 9,+ FRQ XQ LPSDFWRLPSRUWDQWHHQODVXSHUYLYHQFLDDODUJRSOD]R \HQODFDOLGDGGHYLGDGHORVQLxRVLQIHFWDGRV 6LQ HPEDUJR GHEHQ FRQVLGHUDUVH YDULDV OLPLWDFLRQHVGHHVWHWUDWDPLHQWRFRQHOÀQGHHYLWDUR DWHQXDUODDSDULFLyQGHORVHIHFWRVDGYHUVRV9DULRVGHORVHIHFWRVDTXtGHVFULWRVGHEHQWHQHUVH HQFXHQWD\VHUFRQWURODGRVHÀFLHQWHPHQWHSRU HOSHUVRQDOGHODVDOXGTXHDWLHQGHHVWDSREODFLyQFRQHOÀQGHJDUDQWL]DUXQDEXHQDDWHQFLyQ \ FDOLGDG GH YLGD GH HOORV (V SRU HOOR TXH Oas (PSUHVDV 3UHVWDGRUDV GH 6DOXG (36  GHEHUtDQ IRUWDOHFHU HO PDQHMR FOtQLFR GH ORV QLxRV LQIHFWDGRVHLQFOXLUHOPDQHMRGHODVFRPSOLFDFLRQHV GHULYDGDVGHOWUDWDPLHQWRFRQFDPELRVHQHOHVWLORGHYLGDDFRPSDxDPLHQWRSVLFROyJLFR\PRGLÀFDFLyQGHOWUDWDPLHQWR

,QIHFWLR 

(IHFWRVDGYHUVRVGHOWUDWDPLHQWRDQWLUUHWURYLUDOHQQLxRVLQIHFWDGRVSRUHOYLUXVGHODLQPXQRGHÀFLHQFLDKXPDQD

Referencias   

      

  

 







 

 





81$,'681$,'65HSRUWRQWKHJOREDO$,'6HSLGHPLF)HFKD GHFRQVXOWDƒGHQRYLHPEUHGH'LVSRQLEOHHQKWWSZZZ XQDLGVRUJJOREDOUHSRUW(SLBVOLGHVKWP /DOOHPDQW0&KDQJ6&RKHQ53HFRXO%3HGLDWULF+,9$QHJOHFWHG GLVHDVH"1(QJO-0HG 3URJUDPD GH ODV 1DFLRQHV 8QLGDV SDUD HO GHVDUUROOR  &RORPELD &RPEDWLUHO9,+6,'$ODPDODULD\HOGHQJXH)HFKDGHFRQVXOWDGH QRYLHPEUHGH'LVSRQLEOHHQKWWSZZZSQXGRUJFRLPJBXS ORDG&RPEDWLUHO 9,+6,'$OD0DODULD\HO'HQJXHSGI &DUDFRO5DGLR1RWDSHULRGtVWLFD&RORPELDWLHQHPiVGHPLOQLxRV FRQ9,+6LGD)HFKDGHFRQVXOWDƒGHQRYLHPEUHGH'LVSRQLEOHHQZZZFDUDFROFRPFRQRWDDVS["LG  9LYHW%RXGRX9'LGLHUMHDQ-,VHO&0DUTXHW51XFOHRVLGHDQGQXFOHRWLGHLQKLELWRUVRI+,9UHSOLFDWLRQ&HOO0RO/LIH6FL  %ODV*DUFtD $ (VSOXJXHV -9 $SRVWRORYD 1 7ZHQW\ \HDUV RI +,9 QRQQXFOHRVLGH UHYHUVH WUDQVFULSWDVH LQKLELWRUV 7LPH WR UHHYDOXDWH WKHLUWR[LFLW\&XUU0HG&KHP 3p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ySH]3&DLFHGR<5XELDQR/&&RUWpV&$9DOHQFLD$5DPtUH]2 et al $OWHUDFLRQHV PHWDEyOLFDV FRQ WHUDSLD DQWLUUHWURYLUDO DOWDPHQWH HIHFWLYD HQ QLxRV SRVLWLYRV SDUD 9,+ &DOL &RORPELD ,QIHFWLR  )HHQH\ (5 0DOOR 3:* ,QVXOLQ UHVLVWDQFH LQ WUHDWHG +,9 LQIHFWLRQ %HVW3UDFW5HV&OLQ(QGRFULQRO0HWDE %URZQ77/L;&ROH65.LQJVOH\/$3DOHOOD)-5LGGOHU6$et al&XPXODWLYHH[SRVXUHWRQXFOHRVLGHDQDORJXHUHYHUVHWUDQVFULSWDVHLQKLELWRUVLVDVVRFLDWHGZLWKLQVXOLQUHVLVWDQFHPDUNHUVLQWKHPXOWLFHQWHU $,'6FRKRUWVWXG\$,'6 *X]PiQ)XOJHQFLR00LFKHORXG'/RUHQWH5%HOOyQ-0*yPH]0, *XUELQGR0'et al&DUGLRYDVFXODUULVNPDUNHUVDUHLQFUHDVHGLQ+,9 LQIHFWHGFKLOGUHQZLWKOLSRG\VWURSK\V\QGURPH-,QIHFW  %HUHJV]DV]L0'ROOIXV&/HYLQH0)D\H$'HJKPRXQ6%HOODO1 HWDO/RQJLWXGLQDOHYDOXDWLRQDQGULVNIDFWRUVRIOLSRG\VWURSK\DQG DVVRFLDWHGPHWDEROLFFKDQJHVLQ+,9LQIHFWHGFKLOGUHQ-$FTXLU,PPXQH'HÀF6\QGU )LRUH 3 'RQHOOL ( %RQL 6 3RQWDOL ( 7UDPDOORQL 5 %DVVHWWL ' 1XWULWLRQDO VWDWXV FKDQJHV LQ +,9LQIHFWHG FKLOGUHQ UHFHLYLQJ FRPELQHG DQWLUHWURYLUDOWKHUDS\LQFOXGLQJSURWHDVHLQKLELWRUV,QW-$QWLPLFURE $JHQWV 9LJDQz$=XFFRWWL*9&HULQL&6WXFFKL63X]]RYLR0*LDFRPHW9et al/LSRG\VWURSK\LQVXOLQUHVLVWDQFHDQGDGLSRQHFWLQFRQFHQWUDWLRQ LQKLYLQIHFWHGFKLOGUHQDQGDGROHVFHQWV&XUU+,95HV /DJDWKX&.LP00DDFKL09LJRXURX[&&HUYHUD3&DSHDX-HW DO +,9 DQWLUHWURYLUDO WUHDWPHQW DOWHUV DGLSRNLQH H[SUHVVLRQ DQG LQVXOLQ VHQVLWLYLW\ RI DGLSRVH WLVVXH in vitro DQG in vivo %LRFKLPLH  *HUVFKHQVRQ0%ULQNPDQ.0LWRFKRQGULDOG\VIXQFWLRQLQ$,'6DQG LWVWUHDWPHQW0LWRFKRQGULRQ )RVWHU6%0F,QWRVK.7KRPSVRQ%/X0
,QIHFWLR 

 5DLQHV & 5DGFOLIIH 2 7UHLVPDQ *- 1HXURORJLF DQG SV\FKLDWULF FRPSOLFDWLRQV RI DQWLUHWURYLUDO DJHQWV - $VVRF 1XUVHV $,'6 &DUH   1HXHQEXUJ-.%URGW+5+HUQGLHU%*%LFNHO0%DFFKHWWL33ULFH5: et al+,9UHODWHGQHXURSDWKRORJ\WR5LVLQJSUHYDOHQFHRI +,9HQFHSKDORSDWK\LQWKHHUDRIKLJKO\DFWLYHDQWLUHWURYLUDOWKHUDS\ -$FTXLU,PPXQH'HÀF6\QGU  -HUHP\5-.LP61R]\FH01DFKPDQ60F,QWRVK.3HOWRQ6,et al 1HXURSV\FKRORJLFDOIXQFWLRQLQJDQGYLUDOORDGLQVWDEOHDQWLUHWURYLUDO WKHUDS\H[SHULHQFHG+,9LQIHFWHGFKLOGUHQ3HGLDWULFV   &DVWUR30DUWtQH]0<*RQ]iOH],9HOiVTXH]-&DVWLOOR*6iQFKH]/ (YDOXDFLyQQHXURSVLFROyJLFDIDFWRUHVSVLFRVRFLDOHV\FRPRUELOLGDG SVLTXLiWULFDHQSDFLHQWHVSHGLiWULFRVLQIHFWDGRVFRQHO9,+5HY&KLO ,QIHFW  .LHEXUW].=HWWHOPDLHU$(.HWRQHQ/7XLWH0&DLQH('0DQLFV\QGURPHLQ$,'6$P-3V\FKLDWU\  :LOOLDPV'*HUDFL$6LPSVRQ'0$,'6DQG$,'6WUHDWPHQWQHXURSDWKLHV&XUU3DLQ+HDGDFKH5HS  /ySH] 2/ %HFNHU -7 'HZ 0$ &DOGDUDUR 5 5LVN PRGLÀHUV IRU SHULSKHUDO VHQVRU\ QHXURSDWK\ LQ +,9 LQIHFWLRQ$,'6 (XU - 1HXURO   'UDJRYLF * -HYWRYLF ' 1XFOHRVLGH UHYHUVH WUDQVFULSWDVH LQKLELWRU XVDJHDQGWKHLQFLGHQFHRISHULSKHUDOQHXURSDWK\LQ+,9$,'6SDWLHQWV$QWLYLU&KHP&KHPRWKHU  5LFKPDQ'')LVFKO0$*ULHFR0+*RWWOLHE069ROGHUELQJ3$/DVNLQ2/et al7KHWR[LFLW\RID]LGRWK\PLGLQH$=7 LQWKHWUHDWPHQW RI SDWLHQWV ZLWK $,'6 DQG $,'6UHODWHG FRPSOH[ $ GRXEOHEOLQG SODFHERFRQWUROOHGWULDO1(QJO-0HG  $UHQGW*YRQ*LHVHQ+-$QWLUHWURYLUDOWKHUDS\UHJLPHQVIRUQHXUR $,'6&XUU'UXJV7DUJHWV,QIHFW'LVRUGHUV  +DZNLQV 7 *HLVW &